Pfizer: Gene therapy trials for blood diseases

06:41 EST 31 Jan 2020 | SmartBrief

Pfizer announced its plans to begin three late-stage trials this year for gene therapies targeting hemophilia and Duchenne mu -More

Original Article: Pfizer: Gene therapy trials for blood diseases


More From BioPortfolio on "Pfizer: Gene therapy trials for blood diseases"

Quick Search

Relevant Topics

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...